Biomea Fusion, Inc. (BMEA) Financials

BMEA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 46.4 million 27.7 million
Dec. 31, 2025 58.6 million 29.0 million
Sept. 30, 2025 55.2 million 39.6 million
June 30, 2025 73.2 million 45.7 million

BMEA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -11.7 million 1.6 million
Dec. 31, 2025 -13.2 million 1.8 million
Sept. 30, 2025 -12.2 million 1.9 million
June 30, 2025 -19.2 million 2.6 million

BMEA Net Income

No data available :(

BMEA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 44.7 million - -
Dec. 31, 2025 55.8 million - 128000
Sept. 30, 2025 46.6 million - 6.9 million
June 30, 2025 56.2 million - 7.1 million

BMEA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 72.3 million
Dec. 31, 2025 72.3 million
Sept. 30, 2025 40.6 million
June 30, 2025 40.6 million

BMEA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 9.1 million 3.7 million -
Dec. 31, 2025 - 8.1 million 3.6 million -
Sept. 30, 2025 - 14.4 million 4.2 million -
June 30, 2025 - 16.6 million 4.7 million -

BMEA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 46000
Dec. 31, 2025 - 47000
Sept. 30, 2025 - 400000
June 30, 2025 - 500000

BMEA

Price: $1.25

52 week price:
0.87
2.99

Earnings Per Share: -0.55 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 55800

Market Capitalization: 82.1 million

Links: